ATT. 2

North Wales Haematological Cancers Core Multi Disciplinary Team

Membership and Terms of Reference

1. Purpose

·  The core MDT is responsible for the overall running of the North Wales haematological cancers service. It aims to achieve the best possible outcomes for patients by ensuring access to a uniformly high quality of care across North Wales . It does this by defining and monitoring the operational policy by which all clinicians providing haematological cancer services in North Wales should operate; this operational policy is based on best clinical practice and national guidance. The MDT also works with hospitals and specialist centres outside of the North Wales Cancer Network as appropriate.

·  The core MDT is also the main source of clinical advice to the North Wales Cancer Network Management Board on all matters relating to haematology.

2. Membership

·  The membership of the core MDT includes representatives from each site providing treatment as part of the North Wales Haematological Cancers MDT:

o  Ysbyty Gwynedd, Bangor, part of North West Wales NHS Trust

o  Ysbyty Glan Clwyd, Bodelwyddan, part of Conwy and Denbighshire NHS Trust

o  Ysbyty Maelor, Wrexham, part of North East Wales NHS Trust

·  The membership includes representatives of all disciplines involved in the provision of haematology services, and named deputies, in line with Improving Outcomes in Haematological Cancers (NICE, 2003):

o  Haematologists

o  Pathologists

o  Oncologists

o  Radiologists

o  Nurses

o  Palliative care specialists

o  Pharmacists

o  Data co-ordinators

·  Other disciplines may be co-opted to join the group as appropriate.

·  In addition the Network Director, Project Lead and User advisor may be invited as required.

·  The Chair must ensure there is adequate representation from each site and each staff group at the MDT meeting to ensure their full involvement.

3. Chair and Deputy Chair

The Chair and Deputy Chair roles are each for a maximum of five years’ duration. The Chair and Deputy Chair will be nominated by members of the MDT. If there are two or more people nominated, there will be a vote to decide who is elected. The Chair and Deputy Chair will both be agreed by the North Wales Cancer Network Board. The Chair and Deputy Chair will not be from the same Trust.

4. Administrative support

Administrative support will be provided.

5. Frequency of meetings

Meetings will be held at least quarterly.

6. Terms of reference

Service planning

·  To act as the Network advisory group for haematological malignancies, advising on service provision and making recommendations for service improvement/development/ reconfiguration

·  To advise the Network on the implications of national policy issues as they arise

·  To agree an operational policy for the delivery of haematological cancer services across North Wales based on current national guidance and accepted best clinical practice. To review and update this policy annually

·  To agree referral and clinical guidelines for haematological malignancies. To review and update these guidelines annually and audit their implementation

·  To agree the optimum patient pathways for each disease type and audit implementation

Service improvement and redesign

·  To ensure service improvement is embedded within each local team and initiate MDT wide improvements as appropriate

·  To ensure users are involved in the planning and redesign of services

Service quality monitoring

·  To ensure clinical services are delivered in accordance with required national standards i.e. JACIE, WAG cancer standards and NICE Improving Outcomes Guidance.

·  To ensure that the MDT operational policy is implemented effectively on all three sites

·  To ensure adequate facilities and staff exist on each site to allow full implementation of this policy

·  To ensure adequate processes are in place on each site to allow full multi-disciplinary involvement in treatment decisions for individual patients. Where necessary to ensure mechanisms are in place for the North Wales MDT to advise on complex individual cases

·  To agree a minimum data set for haematological malignancies and ensure it is collected on all three sites; to analyse performance and outcome data and take necessary actions

·  To agree and implement an annual audit programme and review the results of these audits

·  To ensure services meet national performance targets and quality standards

·  To address any MDT wide clinical governance concerns raised by local clinical teams

Workforce development

·  To identify core MDT members’ training needs

·  To agree an annual educational programme

Research and development

·  To agree a list of clinical trials, prepare submissions for new trials and ensure all eligible patients are offered the opportunity of entering a clinical trial as appropriate

·  To work with the Network Drugs and Therapeutics group to agree the implementation of new drugs, preparing all necessary submissions

Annual work plan

·  To agree an annual work plan for the MDT

CORE MDT MEMBERS

The core MDT is representative of each core discipline and each site providing treatment as part of the North Wales Haematological Cancers MDT. Additional members of the clinical teams may be invited to attend core team meetings as required.

Name / Title / Location / Cover
Dr D Edwards / Consultant Haematologist (lead) / Ysbyty Gwynedd / Internal cross-cover
Dr J R C Seale / Consultant Haematologist / Ysbyty Gwynedd
Dr C F Hoyle / Consultant Haematologist (deputy) / Ysbyty Glan Clwyd
Dr M J Goodrick / Consultant Haematologist / Ysbyty Glan Clwyd
Dr E Heartin / Consultant Haematologist / Ysbyty Glan Clwyd
Dr D Watson / Consultant Haematologist / Ysbyty Maelor
Dr L DeSoysa / Locum Consultant Haematologist / Ysbyty Maelor
To be agreed / Middle grade / To be agreed
Dr A Nethersell / Consultant Clinical Oncologist / Ysbyty Glan Clwyd / No cover
Dr D J Widdowson / Consultant Radiologist / Ysbyty Glan Clwyd / Internal cross-cover
Dr S Wenham / Consultant Radiologist / Ysbyty Gwynedd
Dr S Dojcinov / Consultant Pathologist / All Wales Lymphoma Panel / Internal cross-cover
Dr R Attanoos / Consultant Pathologist
Linda Jones / Specialist Nurse in Haematology / Ysbyty Gwynedd / Internal cross-cover
Steph Jackson / Haematology Nurse Practitioner / Ysbyty Glan Clwyd
Jayne Samuels / Clinical Nurse Specialist, Haem / Ysbyty Maelor
Dr C Usborne / Consultant in Palliative Care / Ysbyty Glan Clwyd / To be agreed
To be agreed / Pharmacist / To be agreed
Nicola Andrews / Data lead / Ysbyty Glan Clwyd
Graeme Mounsey* / JACIE Project Manager / Ysbyty Gwynedd
Damian Heron* / Director / NWCN
Beryl Roberts* / Lead Nurse / NWCN
Caroline Williams* / Project lead / NWCN
Gillian Evans / User advisor / NWCN/PGLC

* where appropriate; Network officers’ role is to facilitate discussion, problem solve, monitor performance and provide commissioning link